---
title: "12 Health Care Stocks Moving In Thursday's Intraday Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/300061982.md"
description: "During Thursday's intraday session, several healthcare stocks experienced significant volatility. Apimeds Pharmaceuticals surged 162.4% to $6.01, while Surrozen rose 96.16% to $31.7. Other gainers included Greenland Mines, Profusa, GlucoTrack, and Q/C Technologies. Conversely, Artelo Biosciences fell 33.7%, with declines also noted for Bristol-Myers Squibb Celegne Contingent Value Rights, Silexion Therapeutics, Vistagen Therapeutics, Tvardi Therapeutics, and Healthcare Triangle."
datetime: "2026-09-24T17:06:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/300061982.md)
  - [en](https://longbridge.com/en/news/300061982.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/300061982.md)
generator: "portal-rs"
---

# 12 Health Care Stocks Moving In Thursday's Intraday Session

### Gainers

-   **Apimeds Pharmaceuticals** (AMEX:APUS) shares increased by 162.4% to $6.01 during Thursday's regular session. The market value of their outstanding shares is at $3.4 million.
-   **Surrozen** (NASDAQ:SRZN) stock increased by 96.16% to $31.7. The company's market cap stands at $189.9 million.
-   **Greenland Mines** (NASDAQ:GRML) shares rose 36.55% to $15.28. The market value of their outstanding shares is at $35.5 million.
-   **Profusa** (NASDAQ:PFSA) shares increased by 34.63% to $2.76. The company's market cap stands at $1.2 million.
-   **GlucoTrack** (NASDAQ:GCTK) stock increased by 27.09% to $2.58. The market value of their outstanding shares is at $1.6 million.
-   **Q/C Technologies** (NASDAQ:QCLS) stock moved upwards by 26.22% to $1.11. The market value of their outstanding shares is at $7.2 million.

### Losers

-   **Artelo Biosciences** (NASDAQ:ARTL) stock fell 33.7% to $4.84 during Thursday's regular session. The market value of their outstanding shares is at $4.0 million.
-   **Bristol-Myers Squibb Company Celegne Contingent Value Rights** (NYSE:CELGR) shares declined by 19.86% to $0.1.
-   **Silexion Therapeutics** (NASDAQ:SLXN) shares fell 19.73% to $0.25. The market value of their outstanding shares is at $1.7 million.
-   **Vistagen Therapeutics** (NASDAQ:VTGN) shares declined by 19.58% to $0.3. The company's market cap stands at $16.3 million.
-   **Tvardi Therapeutics** (NASDAQ:TVRD) stock declined by 18.57% to $1.07. The market value of their outstanding shares is at $17.6 million.
-   **Healthcare Triangle** (NASDAQ:HCTI) stock fell 18.32% to $0.74. The market value of their outstanding shares is at $1.8 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [ARTL.US](https://longbridge.com/en/quote/ARTL.US.md)
- [SRZN.US](https://longbridge.com/en/quote/SRZN.US.md)
- [HCTI.US](https://longbridge.com/en/quote/HCTI.US.md)
- [APUS.US](https://longbridge.com/en/quote/APUS.US.md)
- [VTGN.US](https://longbridge.com/en/quote/VTGN.US.md)
- [GCTK.US](https://longbridge.com/en/quote/GCTK.US.md)
- [PFSA.US](https://longbridge.com/en/quote/PFSA.US.md)
- [GRML.US](https://longbridge.com/en/quote/GRML.US.md)
- [QCLS.US](https://longbridge.com/en/quote/QCLS.US.md)
- [SLXN.US](https://longbridge.com/en/quote/SLXN.US.md)
- [TVRD.US](https://longbridge.com/en/quote/TVRD.US.md)
- [SRZNW.US](https://longbridge.com/en/quote/SRZNW.US.md)
- [GRMLW.US](https://longbridge.com/en/quote/GRMLW.US.md)
- [NVACW.US](https://longbridge.com/en/quote/NVACW.US.md)
- [SLXNW.US](https://longbridge.com/en/quote/SLXNW.US.md)

## Related News & Research

- [GlucoTrack Tightens Terms in Recent Financing Amendments](https://longbridge.com/en/news/300356119.md)
- [Surrozen says FDA clears IND for SZN-8141 diabetic macular edema trial](https://longbridge.com/en/news/300788834.md)
- [Apimeds unit MindWave Innovations to deploy MindChain blockchain for AQUAEChain platform](https://longbridge.com/en/news/300480172.md)
- [VistaGen Updates Strategy for Pherine-Based CNS Therapies](https://longbridge.com/en/news/300138582.md)
- [GlucoTrack Announces Debt-Reducing Public Equity Offering](https://longbridge.com/en/news/300081340.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**